Home - Chinese Clinical Oncology

New Impact Factor for Chinese Clinical Oncology: 2.1

We are pleased to announce that the Chinese Clinical Oncology (CCO) has attained its latest impact factor for the 2023 citation year: 2.1.

Chinese Clinical Oncology 2023 CiteScore Released: 3.9

We are pleased to announce that the Chinese Clinical Oncology (CCO) has received its 2023 CiteScore: 3.9, ranking 212 out of 404 journals in the Oncology category.

Furthermore, we are delighted to highlight the remarkable achievements made by all AME journals in the CiteScore ranking.

Interviews with Outstanding Authors (2024)

In 2024, many CCO authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors who have been making immense efforts in their research fields, with a brief interview of their unique perspective and insightful view as authors.

Reviewer of the Month (2024)

In 2024, CCO reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

CCO Annual Report (2023)

We are glad to present a brief introduction of CCO’s progress in 2023 here. CCO grew steadily and published 70 papers last year, including 31 Review Articles and 14 Original Articles in total. According to the Google Analytics, CCO journal website had an increasing number of pageviews (all together 214,669 visitors worldwide and 432,642 pageviews in 2023). Two special series have been published, and four special series are ongoing.

‹ ›

Vol 13, No 5 (October, 2024)

Articles in Press

Past Issues

About cco

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

General editorial enquiries:
Email: editor@thecco.net
Copyright related contact:
Email: permissions@amegroups.com
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com

Original Article

Real-world evidence of survival outcomes in breast cancer subtypes after neoadjuvant chemotherapy in a Brazilian reference center

Marcelo Antonini, André Mattar, Fernanda Grace Bauk Richter, Gabriel Duque Pannain, Marina Diogenes Teixeira, Andressa Gonçalves Amorim, Denise Joffily Pereira da Costa Pinheiro, Leonardo Ribeiro Soares, Francisco Pimentel Cavalcante, Marcellus do Nascimento Moreira Ramos, Marcelo Madeira, Felipe Zerwes, Odair Ferraro, Reginaldo Guedes Coelho Lopes, Luiz Henrique Gebrim

PDF Pages: 65 Full Text (236) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

A meta-analysis and systematic review of randomized controlled trials in combination gemcitabine with erlotinib in the pancreatic cancer

Longxiang Yan, Wenming Lu, Wenjin Huang, Alexis Bindzi Zoa, Jiang Zheng, Mingbai Qin, Jing Du, Qiuxiang Xiao, Zhiping Liu, Yuantong Tian

PDF Pages: 66 Full Text (259) Reporting Checklist Peer Review File COI Form Open Access

Short-term outcomes in obese and non-obese patients undergoing transperitoneal laparoscopic adrenalectomy for benign or malignant adrenal diseases: an updated systematic review and meta-analysis

Maurizio Zizzo, Andrea Morini, Magda Zanelli, Chiara Grasselli, Francesca Sanguedolce, Andrea Palicelli, Giuseppe Broggi, Nektarios I. Koufopoulos, Lucia Mangone, Melissa Nardecchia, Angelo Cormio, Rosario Caltabiano, Giulia Besutti, Stefano Ascani, Massimiliano Fabozzi

PDF Pages: 67 Full Text (370) Reporting Checklist Peer Review File COI Form Open Access

Review Article

Primary angiosarcoma of the breast: a literature review

Yidan Zhu, Shogo Nakamoto, Takahiro Tsukioki, Yuko Takahashi, Yoko Iwatani, Tsuguo Iwatani, Xinfeng Zhang, Maki Tanioka, Tadahiko Shien

PDF Pages: 68 Full Text (222) Reporting Checklist Peer Review File COI Form Open Access

Therapeutic inhibition of isocitrate dehydrogenase mutations in glioma and cholangiocarcinoma: new insights and promises—a narrative review

Valeria Internò, Assunta Melaccio, Pasquale Vitale, Roberta Spedaliere, Massimo Buonfantino, Raffaella Messina, Anna Laura Lippolis, Francesco Signorelli, Raffaele Addeo, Francesco Giuliani

PDF Pages: 69 Full Text (179) Reporting Checklist Peer Review File COI Form Open Access

Advancements in cholangiocarcinoma: evolving strategies for diagnosis, treatment, and palliation over three decades

Charbel Elias, Amaan Rahman, Jason Mial-Anthony, Godwin Packiaraj, Andrew Crane, Sarmad Alshamery, Armando Ganoza, Vikraman Gunabushanam, Colin Powers, Stalin Dharmayan, Subashini Ayloo, Hao Liu, Christof Kaltenmeier, Eishan Ashwat, Isabel Neckerman, Berkay Demirors, Michele Molinari

PDF Pages: 70 Full Text (491) Peer Review File COI Form Open Access

Combination makes strength: a narrative review of transarterial radioembolization plus immune checkpoint inhibitors for hepatocellular carcinoma

Rusi Chen, Giovanni Monaco, Bernardo Stefanini, Mariarosaria Marseglia, Stefania De Lorenzo, Francesco Tovoli

PDF Pages: 71 Full Text (236) Reporting Checklist Peer Review File COI Form Open Access

Evidence from resected early-stage non-small cell lung cancer with EGFR mutation: a literature review

Sergio Martinez-Recio, Andres Barba, Margarita Majem

PDF Pages: 72 Full Text (744) Reporting Checklist Peer Review File COI Form Open Access

Phase I trials of single-agent new drugs in head and neck cancer: a scoping review

Daria Maria Filippini, Gregoire Marret, Etienne Bastien, Raphael Sanchez, Edith Borcoman, Christophe Le Tourneau

PDF Pages: 73 Full Text (216) Reporting Checklist Peer Review File COI Form Open Access

Current status, evolution, and future perspectives in robotic platform systems for prostate cancer treatment: a narrative review

Flavia Tamborino, Guglielmo Dello Stritto, Gaetano Salzano, Peppino Lannutti, Marco Mascitti, Alessio Digiacomo, Martina Basconi, Rossella Cicchetti, Angelo Orsini, Matteo Ferro, Riccardo De Archangelis, Luigi Schips, Michele Marchioni

PDF Pages: 74 Full Text (207) Reporting Checklist Peer Review File COI Form Open Access

Case Report

A case report of successful combined intra-arterial immunotherapy and cytokine genetic therapy treatment in a patient with recurrent glioblastoma

Anna V. Alyasova, Amir M. Ben Ammar, Vladimir T. Zarkua, Andrey G. Rerberg

PDF Pages: 75 Full Text (169) Reporting Checklist Peer Review File COI Form Open Access

Editorial Commentary

Combination checkpoint inhibition, angiogenic inhibition and hepatic artery infusion chemotherapy for disease control of advanced hepatocellular carcinoma

Sayed Imtiaz, Mohd Raashid Sheikh

PDF Pages: 76 Full Text (207) Peer Review File COI Form Open Access

Triple combination of hepatic arterial infusion chemotherapy, immune checkpoint inhibitors, and tyrosine kinase inhibitors for treatment of advanced hepatocellular carcinoma: more robust evidence is still needed

Mohammad Saeid Rezaee-Zavareh, Ju Dong Yang

PDF Pages: 77 Full Text (223) Peer Review File COI Form Open Access

The TRIPLET study: more is better?

Salim I. Khakoo

PDF Pages: 78 Full Text (183) Peer Review File COI Form Open Access

Combining immunotherapy/targeted therapy with hepatic artery chemo-infusion in treating patients with advanced hepatocellular carcinoma

Sam Y. Son, Hooman Yarmohammadi

PDF Pages: 79 Full Text (262) Peer Review File COI Form Open Access

Triplet regimen with camrelizumab plus apatinib in combination with hepatic artery infusion chemotherapy (HAIC): a new treatment paradigm for select patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma?

Garima Gupta, Reema Patel, Mehmet Akce, Aman Chauhan

PDF Pages: 80 Full Text (307) Peer Review File COI Form Open Access

Guidelines and Expert Consensus

Guidelines on the diagnosis and treatment of primary liver cancer (2011 edition)

Primary Liver Cancer Diagnosis Treatment Expert Panel

Published online: 01 September 2012

PDF Pages: 10 Full Text (128834) Open Access

Review Article

Staging and response assessment in lymphomas: the new Lugano classification

Bruce D. Cheson

Published online: 30 March 2015

PDF Pages: 5 Full Text (58135) Open Access

Review Article

Advanced magnetic resonance imaging in glioblastoma: a review

Gaurav Shukla, Gregory S. Alexander, Spyridon Bakas, Rahul Nikam, Kiran Talekar, Joshua D. Palmer, Wenyin Shi

Published online: 24 August 2017

PDF Pages: 40 Full Text (48188) Open Access

Review Articles

Percutaneous therapies of hepatocellular carcinoma—an update

Julius Chapiro, Jean-François Henri Geschwind

Published online: 16 December 2013

PDF Pages: 36 Full Text (47030) Open Access

Review Articles

A review of hepatocellular carcinoma (HCC) staging systems

Somasundaram Subramaniam, Robin K. Kelley, Alan P. Venook

Published online: 16 December 2013

PDF Pages: 33 Full Text (44335) Open Access

Review Article

Intrahepatic cholangiocarcinoma: the AJCC/UICC 8^th edition updates

Andrew J. Lee, Yun Shin Chun

Published online: 31 October 2018

PDF Pages: 52 Full Text (41716) Open Access

Review Articles

Colorectal cancer screening: are stool and blood based tests good enough?

Chung-Wah Wu, Joseph Jao-Yiu Sung

Published online: 10 January 2013

PDF Pages: 8 Full Text (40749) Open Access

Review Article

Surgical margins in the management of extremity soft tissue sarcoma

Makoto Endo, Patrick P. Lin

Published online: 30 August 2018

PDF Pages: 37 Full Text (40740) Open Access

Review Article

Primary extranodal B-cell lymphoma: current concepts and treatment strategies

Barbara Vannata, Emanuele Zucca

Published online: 30 March 2015

PDF Pages: 10 Full Text (40668) Open Access

Review Article

Classification of meningiomas—advances and controversies

Patrick N. Harter, Yannick Braun, Karl H. Plate

Published online: 20 July 2017

PDF Pages: S2 Full Text (35688) Open Access

Review Article

The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer

Zahraa Al-Hilli, Judy C. Boughey

Published online: 01 June 2016

PDF Pages: 37 Full Text (34057) Open Access

Review Article

Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations

Lorena Marcano-Bonilla, Essa A. Mohamed, Taofic Mounajjed, Lewis R. Roberts

Published online: 31 October 2016

PDF Pages: 61 Full Text (33627) Open Access

Review Article

BRAF, MEK and KIT inhibitors for melanoma: adverse events and their management

Elisabeth Livingstone, Lisa Zimmer, Julia Vaubel, Dirk Schadendorf

Published online: 01 September 2014

PDF Pages: 29 Full Text (33622) Open Access

Review Article

Imaging of soft tissue sarcomas

Dakshesh B. Patel, George R. Matcuk Jr

Published online: 30 August 2018

PDF Pages: 35 Full Text (30724) Open Access

Review Article

Percutaneous biliary interventions and complications in malignant bile duct obstruction

Hooman Yarmohammadi, Anne M. Covey

Published online: 31 October 2016

PDF Pages: 68 Full Text (30373) Open Access

Review Article

Indications for adjuvant radiation therapy in breast cancer: a review of the evidence and recommendations for clinical practice

Cameron W. Swanick, Benjamin D. Smith

Published online: 01 June 2016

PDF Pages: 38 Full Text (29428) Open Access

Review Article

Epidemiology of gallbladder cancer in India

Usha Dutta, Nikhil Bush, Dimple Kalsi, Priyanka Popli, Vinay K. Kapoor

Published online: 27 August 2019

PDF Pages: 33 Full Text (28077) Open Access

Review Article

Prognostic scores for brain metastasis patients: use in clinical practice and trial design

Vyshak Alva Venur, Manmeet S. Ahluwalia

Published online: 25 June 2015

PDF Pages: 18 Full Text (27725) Open Access

Review Article on Ovarian Cancer

Epidemiology of ovarian cancer

Patricia Gaona-Luviano, Lourdes Adriana Medina-Gaona, Kassandra Magaña-Pérez

Published online: 18 August 2020

PDF Pages: 47 Full Text (27040) COI Form Open Access

Review Article

New approaches in primary central nervous system lymphoma

Eleanor Fraser, Katherine Gruenberg, James L. Rubenstein

Published online: 30 March 2015

PDF Pages: 11 Full Text (26901) Open Access

Full Most Read article list >>

Original Article

Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatments

Laura E. Johnson, Jordan T. Becker, Jason A. Dubovsky, Brian M. Olson, Douglas G. McNeel

Review Article

The spectrum of clinical trials aiming at personalizing medicine

Christophe Le Tourneau, Maud Kamal, Marie Alt, Loic Verlingue, Vincent Servois, Marie-Paule Sablin, Nicolas Servant, Xavier Paoletti

Drug designs fulfilling the requirements of clinical trials aiming at personalizing medicine

Sumithra J. Mandrekar, Daniel J. Sargent

From genomic data analysis to drug development: a new generation of trials using molecular marker assessment in breast cancer

Sophie Doisneau-Sixou, Nadia Harbeck

Melanoma adjuvant therapy

Prashanth M. Thalanayar, Sanjiv S. Agarwala, Ahmad A. Tarhini

Genotyping of cutaneous melanoma

Isabella C. Glitza, Michael A. Davies

Treatment of KIT-mutated metastatic mucosal melanoma

Kevin B. Kim, Anas Alrwas

New approaches in primary central nervous system lymphoma

Eleanor Fraser, Katherine Gruenberg, James L. Rubenstein

Molecular and clinical implementations of ovarian cancer mouse avatar models

Amira A. Zayed, Sumithra J. Mandrekar, Paul Haluska

An overview of the design and conduct of the BATTLE trials

Suyu Liu, J. Jack Lee

Designing a definitive trial for adjuvant targeted therapy in genotype defined lung cancer: the ALCHEMIST trials

Ryan S. Alden, Sumithra J. Mandrekar, Geoffrey R. Oxnard

Risk- and response-adapted strategies for the management of Hodgkin lymphoma

Marcus Remer, Peter W. M. Johnson

Prognostic scores for brain metastasis patients: use in clinical practice and trial design

Vyshak Alva Venur, Manmeet S. Ahluwalia

Strategies for preservation of memory function in patients with brain metastases

Nicholas B. Dye, Vinai Gondi, Minesh P. Mehta

Management of neoplastic meningitis

Patrick Roth, Michael Weller

Design and statistical principles of the SHIVA trial

Xavier Paoletti, Bernard Asselain, Maud Kamal, Nicolas Servant, Philippe Huppé, Ivan Bieche, Christophe Le Tourneau

Autologous tracheal replacement for cancer

Dominique Fabre, Elie Fadel, Sacha Mussot, Frederic Kolb, Nicolas Leymarie, Olaf Mercier, Thierry Le Chevalier, Philippe G. Dartevelle

The staging value of sentinel lymph node biopsy for breast cancer: translating pathologic findings to clinical practice

Jean Bao, Cory Donovan, Alice Chung, Armando E. Giuliano

HER2-positive breast cancer, how far away from the cure?—on the current situation of anti-HER2 therapy in breast cancer treatment and survival of patients

Ning Liao

Training of breast surgical oncologists

Mediget Teshome, Henry M. Kuerer

The way to precision medicine of our team

Fengrui Xu, Xiaodi Wang, Zefei Jiang

Genetic testing for hereditary breast cancer in Asia—moving forward

Ava Kwong

Editorials

Can EGFR mutation status evolve with chemotherapy?

Eric S. Kim, David J. Stewart, Alok A. Khorana

Meta-Analysis

Risk of venous thromboembolism with the erythropoiesisstimulating agents (ESAs) for the treatment of cancer-associated anemia: a meta-analysis of randomized control trials

Ping Zhan, Qin Wang, Qian Qian, Li-Ke Yu

Review Articles

Prevention of colorectal cancer and dietary management

Ningqi Hou, Dezheng Huo, James J. Dignam

Stage II colon cancer

David N. Church, Rachel Midgley, David J. Kerr

Mining the ACCENT database: a review and update

Lindsay A. Renfro, Qian Shi, Daniel J. Sargent

Status of hepatocellular carcinoma in South Korea

Seung Kew Yoon, Hoo Geun Chun

Statistics in Oncology Clinical Trials

Adaptive randomized phase II design for biomarker threshold selection and independent evaluation

Lindsay A. Renfro, Christina M. Coughlin, Axel M. Grothey, Daniel J. Sargent

Adaptive clinical trial designs in oncology

Yong Zang, J. Jack Lee

Statistical aspect of translational and correlative studies in clinical trials

Herbert Pang, Xiaofei Wang

Updates on Surgical Oncology

Clinical trials in lung cancer surgery and research cooperation

Wen-Zhao Zhong, Hao-Ran Zhai, Yi-Long Wu

Below are the latest Chinese Clinical Oncology articles published online ahead of print publication.

Editorial Commentary

Is metastasis-directed local therapy the new standard of care for patients with oligometastasic esophageal squamous cell carcinoma?—a perspective on the ESO-Shanghai 13 Trial

Neil B. Newman, Krishan R. Jethwa

Published online: 17 October 2024

Editorial Commentary

Befotertinib in first-line treatment for Chinese non-small cell lung cancer patients harboring common EGFR-mutations reveals similar efficacy to other third-generation EGFR-TKIs but somewhat different safety profile

Jens Benn Sørensen, Eric Santoni-Rugiu, Edyta Maria Urbanska

Published online: 21 August 2024

Editorial Commentary

Benefit from addition of local therapy in oligometastatic oesophageal squamous cell carcinoma

Yuvnik Trada, Fiona Day, Jarad Martin

Published online: 21 August 2024

Editorial Commentary

Befotertinib: one more drug targeting EGFR—the more may be the merrier

Guilherme Sacchi de Camargo Correia, Yanyan Lou, Rami Manochakian

Published online: 13 August 2024

Editorial Commentary

Artificial intelligence assistance during upper endoscopy: a game changer in detection of esophageal squamous cell carcinoma?

Annemijn D. I. Maan, Arjun D. Koch

Published online: 18 July 2024

Journal Highlight more

The Chinese Clinical Oncology, indexed in MEDLINE/PubMed, ESCI, is an open-access, peer-reviewed medical journal, providing current and practical information on diagnosis, prevention and clinical investigations of cancer. Specific areas of interest include, but not limited to multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention and technical advances related to cancer.